OSU's National Center for Veterinary Parasitology receives $225,000 grant from animal health industr
Tuesday, November 11, 2008
(Nov. 11, 2008 STILLWATER, Okla.) –The Oklahoma State University Foundation today
announced the receipt of $225,000 from Novartis Animal Health to become the National
Center for Veterinary Parasitology’s (NCVP) first industry partner.
This partnership will help accomplish the NCVP’s mission to further the many advances
made in controlling parasitic diseases of animals through integrated programs of applied
graduate and residency training, targeted research initiatives, and a diagnostic and
consulting service that serves the veterinary profession worldwide.
“Novartis shares the Oklahoma State University vision for the Center and will be an
active sponsor in support of its mission,” said Fabian Kausche, M.S., Dr. med vet.,
global head of research and development at Novartis Animal Health. “We look forward
to improving the way we serve the veterinary profession through our involvement in
the NCVP.”
OSU’s NCVP will be a national resource for diagnostic testing and will help fill a
great need for clinically oriented veterinary parasitologists who can meet current
and future demands of the industry.
“In the last several years there has been a decline of veterinary parasitology training
in the U.S.,” said Dr. Michael Lorenz, dean of the Center for Veterinary Health Sciences.
“The NCVP is an opportunity for us to continue training in the discipline of veterinary
parasitology and to provide a source for national diagnostic testing.”
As a founding partner, Novartis will offer the program financial support, help guide
and develop the NCVP as a member of its advisory board, and interact with graduate
students and residents in training.
The Switzerland based Novartis researches, develops and commercializes leading animal
treatments that meet the needs of pet owners, farmers and veterinarians. The global
company operates in more than 40 countries and employs about 2,700 people worldwide.
Through donations and grants, the company has given more than $500,000 to OSU.
Novartis’ $225,000 commitment will help make the center operational by providing support
for laboratory renovations and related start-up costs. Renovations for the Center
are scheduled to begin in 2009 with graduate studies starting in 2010.